These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26476243)

  • 1. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W; Ge C; Yang L; Wang R; Lu Y; Gao Y; Li Z; Wu Y; Zheng X; Wang Z; Zhang C
    Int J Biol Macromol; 2016 Jan; 82():97-103. PubMed ID: 26476243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 5 agonist CBLB502 induces radioprotective effects in vitro.
    Shi T; Li L; Zhou G; Wang C; Chen X; Zhang R; Xu J; Lu X; Jiang H; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):487-495. PubMed ID: 28407032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
    Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
    Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice.
    Bai H; Sun F; Yang G; Wang L; Zhang Q; Zhang Q; Zhan Y; Chen J; Yu M; Li C; Yin R; Yang X; Ge C
    Biol Reprod; 2019 Jan; 100(1):281-291. PubMed ID: 30084935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.
    Burdelya LG; Krivokrysenko VI; Tallant TC; Strom E; Gleiberman AS; Gupta D; Kurnasov OV; Fort FL; Osterman AL; Didonato JA; Feinstein E; Gudkov AV
    Science; 2008 Apr; 320(5873):226-30. PubMed ID: 18403709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
    Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TLR5 agonist inhibits acute renal ischemic failure.
    Fukuzawa N; Petro M; Baldwin WM; Gudkov AV; Fairchild RL
    J Immunol; 2011 Oct; 187(7):3831-9. PubMed ID: 21890657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
    Wang Q; Duan J; Hong J; Ding K; Tai F; Zhu J; Fu H; Zheng X; Ge C
    In Vivo; 2024; 38(4):1636-1648. PubMed ID: 38936936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
    Lai L; Yang G; Yao X; Wang L; Zhan Y; Yu M; Yin R; Li C; Yang X; Ge C
    J Radiat Res; 2019 Nov; 60(6):780-785. PubMed ID: 31599956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of recombinant human neuroglobin as an antioxidant and free radical scavenger.
    Li W; Wu Y; Ren C; Lu Y; Gao Y; Zheng X; Zhang C
    Proteins; 2011 Jan; 79(1):115-25. PubMed ID: 20938977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
    Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
    Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of an antioxidative peptide purified from gastrointestinal digests of oyster, Crassostrea gigas against free radical induced DNA damage.
    Qian ZJ; Jung WK; Byun HG; Kim SK
    Bioresour Technol; 2008 Jun; 99(9):3365-71. PubMed ID: 17904358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant activity and free radical scavenging reactions of hydroxybenzyl alcohols. Biochemical and pulse radiolysis studies.
    Dhiman SB; Kamat JP; Naik DB
    Chem Biol Interact; 2009 Dec; 182(2-3):119-27. PubMed ID: 19665455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid.
    Tarushi A; Karaflou Z; Kljun J; Turel I; Psomas G; Papadopoulos AN; Kessissoglou DP
    J Inorg Biochem; 2013 Nov; 128():85-96. PubMed ID: 23948577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant properties and free radical-scavenging reactivity of a family of hydroxynaphthalenones and dihydroxyanthracenones.
    Rodríguez J; Olea-Azar C; Cavieres C; Norambuena E; Delgado-Castro T; Soto-Delgado J; Araya-Maturana R
    Bioorg Med Chem; 2007 Nov; 15(22):7058-65. PubMed ID: 17845855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 5 agonist inhibition of growth of A549 lung cancer cells in vivo in a Myd88 dependent manner.
    Zhou SX; Li FS; Qiao YL; Zhang XQ; Wang ZD
    Asian Pac J Cancer Prev; 2012; 13(6):2807-12. PubMed ID: 22938463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative properties of ascorbigen in using multiple antioxidant assays.
    Tai A; Fukunaga K; Ohno A; Ito H
    Biosci Biotechnol Biochem; 2014; 78(10):1723-30. PubMed ID: 25273138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro kinetic evaluation of the free radical scavenging ability of propofol.
    Li W; Zhang Y; Liu Y; Yue F; Lu Y; Qiu H; Gao D; Gao Y; Wu Y; Wang Z; Huang R; Zhang C
    Anesthesiology; 2012 Jun; 116(6):1258-66. PubMed ID: 22534248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.